185 related articles for article (PubMed ID: 35686831)
1. Multi-institutional analysis of central nervous system germ cell tumors in patients with Down syndrome.
Harris MK; Graham RT; Cappellano AM; Margol AS; Michaiel G; Crawford JR; Ioakeim-Ioannidou M; Stanek JR; Liu KX; MacDonald SM; Abdelbaki MS
Pediatr Blood Cancer; 2022 Oct; 69(10):e29830. PubMed ID: 35686831
[TBL] [Abstract][Full Text] [Related]
2. 12p gain is predominantly observed in non-germinomatous germ cell tumors and identifies an unfavorable subgroup of central nervous system germ cell tumors.
Satomi K; Takami H; Fukushima S; Yamashita S; Matsushita Y; Nakazato Y; Suzuki T; Tanaka S; Mukasa A; Saito N; Kanamori M; Kumabe T; Tominaga T; Kobayashi K; Nagane M; Iuchi T; Yoshimoto K; Tamura K; Maehara T; Sakai K; Sugiyama K; Yokogami K; Takeshima H; Nonaka M; Asai A; Ushijima T; Matsutani M; Nishikawa R; Ichimura K
Neuro Oncol; 2022 May; 24(5):834-846. PubMed ID: 34698864
[TBL] [Abstract][Full Text] [Related]
3. Brain and Spinal Tumors Originating from the Germ Line Cells.
Wong TT; Tsai ML; Chang H; Hsieh KL; Ho DM; Lin SC; Yen HJ; Chen YW; Lee HL; Yang TF
Adv Exp Med Biol; 2023; 1405():421-455. PubMed ID: 37452948
[TBL] [Abstract][Full Text] [Related]
4. PD-L1 and PD-1 expression in pediatric central nervous system germ cell tumors.
Woods JK; Lidov HG; Ligon KL; Santagata S; Chi SN; Yeo KK; Alexandrescu S
Mod Pathol; 2022 Dec; 35(12):1770-1774. PubMed ID: 36057740
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
6. Histologically confirmed pineal tumors and other germ cell tumors of the brain.
Schild SE; Scheithauer BW; Haddock MG; Wong WW; Lyons MK; Marks LB; Norman MG; Burger PC
Cancer; 1996 Dec; 78(12):2564-71. PubMed ID: 8952565
[TBL] [Abstract][Full Text] [Related]
7. Intracranial Germ Cell Tumors in Adolescents and Young Adults: A 40-Year Multi-Institutional Review of Outcomes.
Lo AC; Hodgson D; Dang J; Tyldesley S; Bouffet E; Bartels U; Cheng S; Hukin J; Bedard PL; Goddard K; Laperriere N
Int J Radiat Oncol Biol Phys; 2020 Feb; 106(2):269-278. PubMed ID: 31654785
[TBL] [Abstract][Full Text] [Related]
8. Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation.
Khatua S; Dhall G; O'Neil S; Jubran R; Villablanca JG; Marachelian A; Nastia A; Lavey R; Olch AJ; Gonzalez I; Gilles F; Nelson M; Panigrahy A; McComb G; Krieger M; Fan J; Sposto R; Finlay JL
Pediatr Blood Cancer; 2010 Jul; 55(1):42-6. PubMed ID: 20222020
[TBL] [Abstract][Full Text] [Related]
9. MRI features of pediatric intracranial germ cell tumor subtypes.
Wu CC; Guo WY; Chang FC; Luo CB; Lee HJ; Chen YW; Lee YY; Wong TT
J Neurooncol; 2017 Aug; 134(1):221-230. PubMed ID: 28551848
[TBL] [Abstract][Full Text] [Related]
10. Recurrent neomorphic mutations of MTOR in central nervous system and testicular germ cell tumors may be targeted for therapy.
Ichimura K; Fukushima S; Totoki Y; Matsushita Y; Otsuka A; Tomiyama A; Niwa T; Takami H; Nakamura T; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Nakazato Y; Hosoda F; Narita Y; Shibui S; Yoshida A; Mukasa A; Saito N; Kumabe T; Kanamori M; Tominaga T; Kobayashi K; Shimizu S; Nagane M; Iuchi T; Mizoguchi M; Yoshimoto K; Tamura K; Maehara T; Sugiyama K; Nakada M; Sakai K; Kanemura Y; Nonaka M; Asai A; Yokogami K; Takeshima H; Kawahara N; Takayama T; Yao M; Kato M; Nakamura H; Hama N; Sakai R; Ushijima T; Matsutani M; Shibata T; Nishikawa R;
Acta Neuropathol; 2016 Jun; 131(6):889-901. PubMed ID: 26956871
[TBL] [Abstract][Full Text] [Related]
11. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications.
Aizer AA; Sethi RV; Hedley-Whyte ET; Ebb D; Tarbell NJ; Yock TI; Macdonald SM
Neuro Oncol; 2013 Jul; 15(7):955-60. PubMed ID: 23640532
[TBL] [Abstract][Full Text] [Related]
12. Relapsing intracranial germ cell tumours warrant retreatment.
Callec L; Lardy-Cleaud A; Guerrini-Rousseau L; Alapetite C; Vignon L; Chastagner P; Frappaz D; Faure-Conter C
Eur J Cancer; 2020 Sep; 136():186-194. PubMed ID: 32711377
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and immunohistochemical features of primary central nervous system germ cell tumors: a 24-years experience.
Gao Y; Jiang J; Liu Q
Int J Clin Exp Pathol; 2014; 7(10):6965-72. PubMed ID: 25400782
[TBL] [Abstract][Full Text] [Related]
14. Intracranial germ cell tumors: a single-institution experience.
Khafaga Y; El Weshi A; Nazmy M; Hassounah M; Alshail E; Moussa E; Allam A; Alkofide A; Jamshed A; ELhusseiny G; Ezzat I; Jenkin D
Ann Saudi Med; 2012; 32(4):359-65. PubMed ID: 22705605
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of intracranial non-germinomatous germ cell tumors: a retrospective Asian multinational study on treatment strategies and prognostic factors.
Hong KT; Han JW; Fuji H; Byun HK; Koh KN; Wong RX; Lee HL; Yoon HI; Lee JH; Phi JH; Kim SK; Kim DS; Lyu CJ; Choi JY; Kang HJ; Chen YW; Lee YY; Im HJ; Ra YS; Do Ahn S; Low SYY; Looi WS; Park HJ; Suh YG; Suh CO; Wang KC; Tan EEK; Wong TT; Kim JY
J Neurooncol; 2022 Oct; 160(1):41-53. PubMed ID: 36045266
[TBL] [Abstract][Full Text] [Related]
16. Pediatric central nervous system germ cell tumors: a review.
Echevarría ME; Fangusaro J; Goldman S
Oncologist; 2008 Jun; 13(6):690-9. PubMed ID: 18586924
[TBL] [Abstract][Full Text] [Related]
17. The clinical characteristics and treatment outcome of 57 children and adolescents with primary central nervous system germ cell tumors.
Sun XF; Zhang F; Zhen ZJ; Yang QY; Xia YF; Wu SX; Zhu J; Lu SY; Wang J; Sun FF; Cai RQ; Chen Y; Li PF
Chin J Cancer; 2014 Aug; 33(8):395-401. PubMed ID: 25011460
[TBL] [Abstract][Full Text] [Related]
18. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of intensive chemotherapy followed by reduced-dose and reduced-field irradiation for intracranial germ cell tumor.
Takada A; Ii N; Hirayama M; Toyoda H; Matsubara T; Toyomasu Y; Kawamura T; Daimon T; Sakuma H; Nomoto Y
J Neurosurg Pediatr; 2018 Nov; 23(3):317-324. PubMed ID: 30497152
[TBL] [Abstract][Full Text] [Related]
20. T2*-based MR imaging (gradient echo or susceptibility-weighted imaging) in midline and off-midline intracranial germ cell tumors: a pilot study.
Morana G; Alves CA; Tortora D; Finlay JL; Severino M; Nozza P; Ravegnani M; Pavanello M; Milanaccio C; Maghnie M; Rossi A; Garrè ML
Neuroradiology; 2018 Jan; 60(1):89-99. PubMed ID: 29128947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
